Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Hemasphere
|
March 21, 2022
Cellular and gene therapy
Rose Ann Padua
Discovery Medicine
|
August 14, 2010
Use of animal models for the treatment of leukemias: Efficacy of DNA vaccination combined with ATRA
Rose Ann Padua, Christine Chomienne
Haematologica
|
October 16, 2012
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?
Stephanie Beurlet, Christine Chomienne, Rose Ann Padua
Cancer Immunology, Immunotherapy : CII
|
May 13, 2005
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans
Marie Robin, Marie-Hélène Schlageter, Christine Chomienne, et al.
Seminars in Cancer Biology
|
February 6, 2004
Targeted therapies in myeloid leukemia
Alison M John, N Shaun B Thomas, Ghulam J Mufti, et al.
Antimicrobial Agents and Chemotherapy
|
January 25, 2003
Genetics of mefloquine resistance in the rodent malaria parasite Plasmodium chabaudi
Pedro V L Cravo, Jane M-R Carlton, Paul Hunt, et al.
Drug Discovery Today
|
December 30, 2009
Isotopic biomarker discovery and application in translational medicine
Henry K Bayele, Arturo Chiti, Rodney Colina, et al.
Experimental Hematology
|
February 16, 2011
Identification of JAK2 mutations in canine primary polycythemia
Stephanie Beurlet, Patricia Krief, Arnaud Sansonetti, et al.
Blood
|
January 6, 2005
Farnesyltransferase inhibitor tipifarnib (R115777) preferentially inhibits in vitro autonomous erythropoiesis of polycythemia vera patient cells
Jérôme Larghero, Nathalie Gervais, Bruno Cassinat, et al.
Molecular Cancer Research : MCR
|
August 1, 2006
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?
Terry J Gaymes, Rose Ann Padua, Marika Pla, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Hemasphere
|
March 21, 2022
Cellular and gene therapy
Rose Ann Padua
Discovery Medicine
|
August 14, 2010
Use of animal models for the treatment of leukemias: Efficacy of DNA vaccination combined with ATRA
Rose Ann Padua, Christine Chomienne
Haematologica
|
October 16, 2012
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?
Stephanie Beurlet, Christine Chomienne, Rose Ann Padua
Cancer Immunology, Immunotherapy : CII
|
May 13, 2005
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans
Marie Robin, Marie-Hélène Schlageter, Christine Chomienne, et al.
Seminars in Cancer Biology
|
February 6, 2004
Targeted therapies in myeloid leukemia
Alison M John, N Shaun B Thomas, Ghulam J Mufti, et al.
Antimicrobial Agents and Chemotherapy
|
January 25, 2003
Genetics of mefloquine resistance in the rodent malaria parasite Plasmodium chabaudi
Pedro V L Cravo, Jane M-R Carlton, Paul Hunt, et al.
Drug Discovery Today
|
December 30, 2009
Isotopic biomarker discovery and application in translational medicine
Henry K Bayele, Arturo Chiti, Rodney Colina, et al.
Experimental Hematology
|
February 16, 2011
Identification of JAK2 mutations in canine primary polycythemia
Stephanie Beurlet, Patricia Krief, Arnaud Sansonetti, et al.
Blood
|
January 6, 2005
Farnesyltransferase inhibitor tipifarnib (R115777) preferentially inhibits in vitro autonomous erythropoiesis of polycythemia vera patient cells
Jérôme Larghero, Nathalie Gervais, Bruno Cassinat, et al.
Molecular Cancer Research : MCR
|
August 1, 2006
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?
Terry J Gaymes, Rose Ann Padua, Marika Pla, et al.
Page
of 4